Afayro 30 Tablet
CompositionAfatinib dimaleate (30mg)
RxPrescription Required
Packbottle of 28 tablets
StorageStore below 30°C
Chemical ClassQuinazoline and Butenamide Derivative
Action ClassTyrosine Kinase Inhibitors (TKIs)
ManufacturerGlenmark Pharmaceuticals Ltd
Afayro 30 Tablet is used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain mutations of epidermal growth factor receptor (EGFR).


